International
Dragon Pharma Testagen 20 mg KEDG Research Peptide Vial
Injection · 20 mg · vial
Dragon Pharma Testagen is the KEDG tetrapeptide, a bioregulator supplied as a 20 mg lyophilized vial. Vendor material gives it a testicular and male reproductive accent; it is not a hormone, does not replace testosterone therapy and no human effect on testosterone is recorded.
GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. Testagen 20 mg for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma Testagen 20 mg KEDG Tetrapeptide Vial
Dragon Pharma Testagen is a 20 mg lyophilized vial of the KEDG tetrapeptide from the same Russian bioregulator series as Livagen and Ovagen. In that family the accent of this member is male reproductive tissue, and every vendor page in the fact sheet repeats the same sequence, KEDG, which makes the identity easy to check but adds little clinical weight. The pack is a single vial of powder for reconstitution.
- 20 mg lyophilized powder in a single vial - research use
- Short regulatory tetrapeptide, sequence KEDG
- GMP-manufactured and HPLC-verified - COA on file per batch
- U.S. domestic and international shipping
How Testagen Works
The honest starting point is what the peptide is not: it is not a hormone, not a testosterone ester and not a substitute for hormone replacement, and the fact sheet records no separate effect on human testosterone levels. What the sources do contain is molecular work on the peptide family, where short peptides are studied in relation to histone proteins and promoter accessibility - a dish-level mechanism, not a clinical endpoint. There are no randomised human trials for Testagen and no published half-life. Work on male hormone signalling that does have measurable endpoints, such as HCG for testicular signalling and Enclomiphene for endogenous testosterone, is documented separately on those pages.
Reconstitution & Storage
Add bacteriostatic water against the vial wall and swirl without shaking. A 20 mg vial in 2 ml gives 10 mg/ml, where 1 mg is 0.1 ml or 10 units on a U-100 syringe; 1 ml of diluent doubles that concentration, so 1 mg becomes 0.05 ml. Vendor material mentions 0.5-2 mg per day and the family format is a one to three week block, so a vial at 1 mg per day covers 20 days. Store the powder at 2-8 C, away from light, and use a solution within about 28 to 30 days.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis held per batch. Keep the vial upright, protect it from light and avoid repeated freeze-thaw cycles. The other two members of the family are on the Livagen and Ovagen pages if you are comparing the three sequences.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | Testagen |
| Generic Name | Short regulatory tetrapeptide, sequence KEDG |
| Manufacturer | Dragon Pharma |
| Dosage | 20 mg per vial |
| Package | 1 lyophilized vial |
| Drug Class | Research peptide, short bioregulator |
| Half-Life | Not established in humans |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
Research compounds only. Consult a healthcare professional before any use. Amounts shown are vendor and project-family practice, not clinical doses.
FAQ
Before you ask
Questions, answered
It is the KEDG tetrapeptide of the Russian bioregulator series, positioned in a male reproductive context by vendor material. The supported science is cell-level and concerns histone proteins and promoter accessibility, which is a mechanism rather than a clinical result. No approved indication, no human trial program and no pharmacokinetic profile exist for the peptide.
No effect on human testosterone levels is recorded in the sources, and the fact sheet is explicit that the peptide is not a hormone and does not replace testosterone replacement therapy. Anything claimed about male hormone output should come from bloodwork on compounds with real endpoints, such as Enclomiphene or HCG, not from a research peptide with no human data.
Add bacteriostatic water against the wall of the vial and swirl gently, do not shake. Two ml in a 20 mg vial gives 10 mg/ml, where 1 mg equals 0.1 ml or 10 units on a U-100 syringe; one ml gives 20 mg/ml and 1 mg equals 0.05 ml, so use a low-volume syringe for accuracy. Store the solution at 2-8 C and use it within about 28 to 30 days.
Local reactions dominate what is described for this family: pain, redness and itching at the injection site, handled by site rotation and clean technique. A peptide allergy is possible, so a small test amount first is reasonable. Long-term human safety data do not exist, since the family has never been through randomised human trials, and that is the main constraint on any interpretation.
All three come from the same short-peptide series and differ by sequence and by the tissue accent used in vendor copy: KEDG with the male reproductive angle here, KEDA with the liver angle on the Livagen page, EDL with the hepatic and gastrointestinal angle on the Ovagen page. None of the three has human outcome data, so the difference between them rests on sequence and positioning rather than on measured effects.
Keep the lyophilized vial at 2-8 C, protected from light, and do not freeze the powder repeatedly. Once reconstituted, hold the solution at 2-8 C and use it within about 28 to 30 days. GenXXLGear ships Testagen 20 mg with U.S. domestic and international shipping, and every batch carries a Certificate of Analysis from third-party HPLC testing.
Be the first to share your experience with Dragon Pharma Testagen 20 mg KEDG Research Peptide Vial
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
U.S Domestic
Available Domestic